Doody E, Groebner J, Walker J, Frizol B, Tuma D, Fernandez D, et al. Ethanol metabolism by alcohol dehydrogenase or cytochrome P450 2E1 differentially impairs hepatic protein trafficking and growth hormone signaling. Am J Physiol Gastrointest Liver Physiol. 2017;313:G558-G569 pubmed publisher

Sawada T, Arai D, Jing X, Miyajima M, Frank S, Sakaguchi K. Molecular interactions of EphA4, growth hormone receptor, Janus kinase 2, and signal transducer and activator of transcription 5B. PLoS ONE. 2017;12:e0180785 pubmed publisher

Lin H, Gutenberg A, Chen T, Tsai N, Lee C, Cheng Y, et al. In Situ Activation of Pituitary-Infiltrating T Lymphocytes in Autoimmune Hypophysitis. Sci Rep. 2017;7:43492 pubmed publisher

Pednekar L, Pandit H, Paudyal B, Kaur A, Al Mozaini M, Kouser L, et al. Complement Protein C1q Interacts with DC-SIGN via Its Globular Domain and Thus May Interfere with HIV-1 Transmission. Front Immunol. 2016;7:600 pubmed publisher

Wong K, Chan G, Ho E, Wan T. Simultaneous detection of recombinant growth hormones in equine plasma by liquid chromatography/high-resolution tandem mass spectrometry for doping control. J Chromatogr A. 2016;1478:35-42 pubmed publisher

Pang Y, Tan Y, Li Y, Zhang J, Guo Y, Guo Z, et al. Serum A08 C1q antibodies are associated with disease activity and prognosis in Chinese patients with lupus nephritis. Kidney Int. 2016;90:1357-1367 pubmed publisher

López Olmeda J, Pujante I, Costa L, Galal Khallaf A, Mancera J, Sanchez Vazquez F. Daily rhythms in the somatotropic axis of Senegalese sole (Solea senegalensis): The time of day influences the response to GH administration. Chronobiol Int. 2016;33:257-67 pubmed publisher

So W, Cheng Q, Xu A, Lam K, Leung P. Loss of fibroblast growth factor 21 action induces insulin resistance, pancreatic islet hyperplasia and dysfunction in mice. Cell Death Dis. 2015;6:e1707 pubmed publisher

Deeb A, Attia S, Elhag G, El Fatih A, Reddy J, Nagelkerke N. Pituitary gland size is a useful marker in diagnosing isolated growth hormone deficiency in short children. J Pediatr Endocrinol Metab. 2015;28:981-4 pubmed publisher

Bielohuby M, Zarkesh Esfahani S, Manolopoulou J, Wirthgen E, Walpurgis K, Toghiany Khorasgani M, et al. Validation of serum IGF-I as a biomarker to monitor the bioactivity of exogenous growth hormone agonists and antagonists in rabbits. Dis Model Mech. 2014;7:1263-73 pubmed publisher

Lin G, LaPensee C, Qin Z, Schwartz J. Reciprocal occupancy of BCL6 and STAT5 on Growth Hormone target genes: contrasting transcriptional outcomes and promoter-specific roles of p300 and HDAC3. Mol Cell Endocrinol. 2014;395:19-31 pubmed publisher

Thankamony A, O Connell S, Kirk J, Donaldson M, Ivarsson S, Soder O, et al. A randomised controlled trial evaluating IGF1 titration in contrast to current GH dosing strategies in children born small for gestational age: the North European Small-for-Gestational-Age Study. Eur J Endocrinol. 2014;171:509-18 pubmed publisher

Schlederer M, Mueller K, Haybaeck J, Heider S, Huttary N, Rosner M, et al. Reliable quantification of protein expression and cellular localization in histological sections. PLoS ONE. 2014;9:e100822 pubmed publisher

Choukair D, Hügel U, Sander A, Uhlmann L, Tönshoff B. Inhibition of IGF-I-related intracellular signaling pathways by proinflammatory cytokines in growth plate chondrocytes. Pediatr Res. 2014;76:245-51 pubmed publisher

Zerrad Saadi A, Prip Buus C, Fauveau V, Helmy N, Ziol M, Vons C, et al. GH administration rescues fatty liver regeneration impairment by restoring GH/EGFR pathway deficiency. Endocrinology. 2014;155:2545-54 pubmed publisher